#Clinical Trials
24 articles with this tag
Imperial College London Boosts Dementia Care with Data Platform
Imperial College London's dementia research team leverages a modern Databricks data platform to integrate IoT, clinical, and research data, accelerating care insights and improving patient outcomes.
ChemoCentryx Data Fraud Allegations Surface
Allegations of data manipulation at ChemoCentryx have resurfaced, casting doubt on FDA-approved drug trial results and raising questions about Amgen's acquisition.
Triomics Secures $22M for Cancer Data AI
Triomics raises $22 million in Series B funding to scale its AI platform, tackling information overload in oncology and improving patient care.
Databricks Unifies Clinical Data
Databricks' new open-source Site Feasibility Workbench brings clinical trial intelligence onto its Lakehouse, tackling data silos and improving auditability.
Google DeepMind's AI clinician aims to aid doctors
Google DeepMind is developing an AI co-clinician to assist doctors, improve patient care, and address healthcare worker shortages, exploring multimodal interactions.
Databricks Aims to Speed Up Drug Trials
Databricks Genie aims to slash clinical trial delays by enabling natural language interrogation of complex data, speeding up treatment approvals and patient access.
TriNetX Speeds Drug Trials With Databricks
TriNetX uses Databricks' AI platform to significantly speed up drug development, cutting trial delays and improving research efficiency.
Sonomind Funding Fuels €3M Push for Novel Brain Stimulation
Paris-based Sonomind, a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).
Sonomind Funding Fuels €3M Push for Novel Brain Stimulation
Paris-based Sonomind, a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).
Treeline Biosciences Raises $200M, Initiates Clinical Trials
The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Zurich-based Mabylon, a Swiss biotech scale-up, secured €31.8 million in new funding. This Mabylon funding round will advance its lead peanut allergy program.
Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline
Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.
Comphya Secures €8M Series A for ED Neurostimulation
Lausanne-based Comphya SA, a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.
Comphya Secures €8M Series A for ED Neurostimulation
Lausanne-based Comphya SA, a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.
CNBC Disruptor 50 on Formation Bio to Redefine Drug Development
Neuralink Secures Massive $650M Series E Funding
Vivodyne Secures $40 Million to Revolutionize Drug Discovery
Veltist Secures €160,000 in Funding for Innovative Surgical Patch
Veltist, a medtech startup spun out of ETH Zurich and Empa, has successfully raised €160,000 (CHF 150,000) in seed funding from Venture Kick.
Veltist Secures €160,000 in Funding for Innovative Surgical Patch
Veltist, a medtech startup spun out of ETH Zurich and Empa, has successfully raised €160,000 (CHF 150,000) in seed funding from Venture Kick.
MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry
Zetaris Launches AI Clinical Assistant for Improved Healthcare Outcomes
AI and Spatial Biology Startup Nucleai Secured $14 Million Led by M Ventures
Accenture Ventures Backs QuantHealth, Clinical Trial Simulations
